{"id":"W2140055441","doi":"10.1200/jco.2008.20.6847","title":"Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"F. Hoffmann-La Roche; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"Anastrozole; Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Hazard ratio; Oncology; Breast cancer; Aromatase inhibitor; Gynecology; Cancer; Tamoxifen; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005398737,0.0004657961,0.004309883,0.0001463213,0.0003057697,0.000037925,0.0005020463,0.000211404,0.0002673311],"category_scores_gemma":[0.001687108,0.0002235639,0.0006249865,0.0003559278,0.0009306339,0.0001783767,0.00004351179,0.001058192,0.0000035301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002152309,"about_ca_system_score_gemma":0.003118002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00141474,"about_ca_topic_score_gemma":0.0004151347,"domain_scores_codex":[0.9911047,0.002771692,0.003693726,0.0005302792,0.001140434,0.0007592262],"domain_scores_gemma":[0.9754562,0.01910443,0.002965193,0.0004736556,0.001357717,0.0006428548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8692489,0.01295217,0.0004964037,0.00000642427,0.008329374,0.0002063151,0.005314817,0.00005007728,0.001505014,0.00001492114,0.0024773,0.09939834],"study_design_scores_gemma":[0.6699985,0.2495139,0.07060336,0.0001101166,0.002884705,0.00006199613,0.004747265,0.0001297756,0.0006227593,0.00003267894,0.001104923,0.0001899796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707783,0.0010882,0.000495592,0.02054842,0.0006116487,0.004513542,0.001828485,0.00001522341,0.0001205743],"genre_scores_gemma":[0.9937772,0.0020087,0.00140945,0.0006137596,0.00173352,0.0002421664,0.00007686402,0.00004507213,0.00009327806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2365618,"threshold_uncertainty_score":0.9116669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1158062761522462,"score_gpt":0.47668609962928,"score_spread":0.3608798234770338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}